NIH-funded research NIH-funded research

Deciphering RNA-Related Blood-Brain Barrier Breakdown in C9orf72-Linked Frontotemporal Dementia

Official title: Deciphering RNA-Mediated Blood-Brain Barrier Dysfunction in C9orf72-Linked Frontotemporal Dementia (FTD)

Funded at University of Vermont & St Agric College · NIH-11335687 · Data updated 2026-11-12

A patient-focused look at how harmful RNA buildup in a gene linked to frontotemporal dementia may weaken the brain’s protective barrier and what that could mean for future therapies.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Vermont & St Agric College
NIH-funded
Lab location1 site (Burlington, United States)
Project startDecember 1, 2020
Project endMarch 31, 2031
Funding year2026
Award (this year)$282,439
NIH project number2P20GM135007-06A1
Project IDNIH-11335687 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are individuals with or at risk for C9orf72-related frontotemporal dementia or those who can provide related biological samples for study.

Less likely to help

Individuals without C9orf72-related risk or related samples may not directly benefit from this research.

What this research studies

This project studies how specific RNA toxicity from the C9orf72 gene might disrupt the blood-brain barrier, a critical shield protecting the brain. Researchers will use human-relevant models to explore how astrocytes (brain support cells) contribute to barrier stability and test a new RNA-targeting tool to fix the problem. The goal is to map the molecular steps from RNA toxicity to barrier dysfunction and neurodegeneration so future treatments can target these steps. The work combines advanced 3-D models and molecular approaches to connect cellular changes with potential therapies.

Why it matters

Potential benefit: If successful, the work could guide new therapies that restore brain barrier function and slow or prevent progression of C9orf72-related frontotemporal dementia.

How similar studies have gone: Preliminary data suggest that targeting RNA toxicity can restore astrocyte support and vascular stability, supporting potential for similar approaches.

Where this research is happening

  • University of Vermont & St Agric College
    Burlington, United States
    Active

Researchers

  • Principal investigator: Morelli, Kathryn H — University of Vermont & St Agric College
  • Study coordinator: Morelli, Kathryn H

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.